The nominees were evaluated and two winners selected by a Judging Panel of three world-renowned cardiologists.
Chairman: Douglas P. Zipes Distinguished Professor of Medicine, Pharmacology and Toxicology and the Director of the Cardiology Division and Krannert Institute of Cardiology at Indiana University in Indianapolis, Indiana.
Douglas P. Zipes is a Distinguished Professor of Medicine, Pharmacology and Toxicology and the Director of the Cardiology Division and Krannert Institute of Cardiology at Indiana University in Indianapolis, Indiana.
Dr. Zipes has been honored for his scientific contributions many times and was the recipient of the Sagamore of the Wabash award (the highest award of honor in Indiana) in 2001 and the Herrick Award from the American Heart Association in 1997. He was also awarded the Distinguished Scientist Award from the American College of Cardiology in 1996.
Dr. Zipes is past President and Chairman of the Executive Committee of the American College of Cardiology. He is also a past Member of the Board of Directors at the American Heart Association and has served in many additional leadership roles at other U.S. and international cardiology and medical associations.
In addition to publishing hundreds of peer-reviewed research papers on various topics within the field of cardiology, Dr. Zipes is the Editor-in-Chief of Cardiology in Review and Journal of Cardiovascular Cardiology in Review. He also serves on the editorial board of many other peer-reviewed journals.
Dr. Zipes received a Bachelor of Arts and a Bachelor of Medical Science from Dartmouth College in Hanover, New Hampshire. He earned his medical degree from Harvard Medical School in Boston, Massachusetts. After graduation, he spent 4 years in postdoctoral training at Duke University Medical Center in Durham, North Carolina, specializing in cardiology.
Karl Swedberg Professor of Medicine at The Cardiovascular Institute at Goteborg University in Goteborg, Sweden. He also is a Senior Physician at the Department of Medicine at Sahlgrenska University Hospital/Ostra also in Goteborg, Sweden.
Karl Swedberg is a Professor of Medicine at The Cardiovascular Institute at Goteborg University in Goteborg, Sweden. He also is a Senior Physician at the Department of Medicine at Sahlgrenska University Hospital/Ostra also in Goteborg, Sweden.
Dr. Swedberg has participated on the Steering Committee and Data Safety Monitoring Board of over 30 large clinical trials. His research interests include treatment of chronic heart failure, neuroendocrine activation in heart failure, and early intervention and monitoring in ischemic heart disease. In addition, he has done research in the fields of myocardial function and skeletal muscle metabolism in congestive heart failure.
Dr. Swedberg is past President of the Swedish Society of Cardiology and the Chairman of the Scientific Board of the Scandinavian Clinical Research Institute. He is also a Fellow at the European Society of Cardiology, the American Heart Association and the American College of Cardiology.
In addition to publishing hundreds of peer-reviewed research papers on various topics within the field of cardiology during his career, Dr. Swedberg is also on the editorial board of several journals including, European Heart Journal and European Journal of Heart Failure.
Dr. Swedberg earned his Medical Degree from the University of Umea in Umea, Sweden. He then earned a Doctorate of Medicine from Goteborg University. After graduation, he was a Visiting Associate Professor and earned the Fogarthy Foundation Fellowship in the Division of Cardiology at the University of California in San Francisco, United States.
Peter Libby MD, Chief of Cardiovascular Medicine at the Brigham & Women's Hospital, Boston, Massachusetts. He also serves as the Mallinckrodt Professor of Medicine at Harvard Medical School.
Peter Libby, MD, is the Chief of Cardiovascular Medicine at the Brigham & Women's Hospital, Boston, Massachusetts. He also serves as the Mallinckrodt Professor of Medicine at Harvard Medical School. Dr. Libby's current major research focus is the role of inflammation in vascular diseases such as atherosclerosis. He has received numerous awards and recognitions for his research accomplishments. His areas of clinical expertise include general and preventive cardiology.
An extensive author and lecturer on cardiovascular medicine and atherosclerosis, Dr. Libby has published numerous research articles in medical journals including Circulation, The Journal of Clinical Investigation, The Proceedings of the National Academy of Sciences, The New England Journal of Medicine, and Nature. He is co-Editor of Braunwald's Heart Disease, Edition 6. Dr. Libby also contributed the chapters on the pathogenesis, treatment, and prevention of atherosclerosis to the 15th edition of Harrison's Principles of Internal Medicine. He has held numerous Visiting Professorships and has been selected to deliver named Lectures throughout the world on many occasions.
Dr. Libby is a Member of the Association of American Physicians and the American Society for Clinical Investigation. He has served in many roles as a volunteer for the American Heart Association, including Chairmanship of several research committees and Membership in the Executive Committees of the Councils on Arteriosclerosis, Circulation, and Basic Science. He has also served as a frequent consultant to the National Heart, Lung and Blood Institute, and has recently completed a five-year term on the Board of Scientific Councilors. He is the recipient of a MERIT Award from the Institute.
Dr. Libby earned his Medical Degree at the University of California, San Diego and completed his training in internal medicine and cardiology at the Peter Bent Brigham Hospital (currently Brigham & Women's Hospital). He also holds an honorary Master of Arts Degree from Harvard University.